2016 European Guidelines on cardiovascular disease prevention in clinical practice
By T. Ivanova. 2016
633 citations recorded by the source corpus.
Authors/Task Force Members: Massimo F. Piepoli* (Chairperson) (Italy), Arno W. Hoes* (Co-Chairperson) (The Netherlands), Stefan Agewall (Norway)1, Christian Albus (Germany)9, Carlos Brotons (Spain)10, Alberico L. Catapano (Italy)3, Marie-Therese Cooney (Ireland)1, Ugo Corrà (Italy)1, Bernard Cosyns (Belgium)1, Christi Deaton (UK)1, Ian Graham (Ireland)1, Michael Stephen Hall (UK)7, F. D. Richard Hobbs (UK)10, Maja-Lisa Løchen (Norway)1, Herbert Löllgen (Germany)8, Pedro Marques-Vidal (Switzerland)1, Joep Perk (Sweden)1, Eva Prescott (Denmark)1, Josep Redon (Spain)5, Dimitrios J. Richter (Greece)1, Naveed Sattar (UK)2, Yvo Smulders (The Netherlands)1, Monica Tiberi (Italy)1, H. Bart van der Worp (The Netherlands)6, Ineke van Dis (The Netherlands)4, W. M. Monique Verschuren (The Netherlands)1
Subfields: Economics and Econometrics, Information Systems
View Paper: https://www.semanticscholar.org/paper/72dbf1b62d60e1e2f429aa6deb8fe61d65d4f9a6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- G. Pearson
- D. Lau
- G. Thanassoulis
- A. Barry
- J. Stone
- G. Mancini
- P. Couture
- J. Genest
Citations in the corpus
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. (2016, positive): “64,65 (5) The use of lipid targets might aid clinicians in optimizing lipid-lowering therapy, and might reinforce patient adherence and provide evidence for patients of the ef fi cacy of treatment.”